Sensorium Therapeutics

Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensoriums groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world. Visit sensorium.bio to learn more

Biotechnology,research,drug discovery,and mental health

Sensorium therapeutics operates in the Biotechnology research industry.

Sensorium therapeutics's revenue is 11m - 100m

Sensorium therapeutics has 11 - 50 employees.